Home
About
Services
Partners
Client Portfolio
News
Contact
BlackRock pulls out of rescue bid for Italian bank Carige
May 9, 2019
Kraft Heinz launches sale of baby food unit: sources
May 9, 2019
0
Novartis buys dry eye drug from Takeda for up to $5.3 billion
Published by
Muller&Green
at
May 9, 2019
Categories
RSS
Tags
Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more